Is intravenous lipid infusion associated with fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Intravenous Lipid Infusion and Fever

Yes, intravenous lipid infusion is associated with fever, specifically as part of fat overload syndrome (FOS), which occurs with rapid or excessive lipid administration.

Fat Overload Syndrome: The Key Association

Fever is a well-documented component of fat overload syndrome, which develops when lipid emulsions are infused too rapidly or at excessive doses, overwhelming the body's lipoprotein lipase capacity 1. FOS presents with a characteristic constellation of symptoms including fever, headaches, jaundice, hepatosplenomegaly, respiratory distress, and spontaneous hemorrhage 1, 2.

Clinical Presentation

The syndrome also manifests with:

  • Hematologic abnormalities: anemia, leukopenia, thrombocytopenia
  • Coagulopathy with low fibrinogen levels
  • Reticuloendothelial system (RES) overload with fat 1

Critical Mechanism

When lipid infusion rates exceed the capacity of lipoprotein lipase to clear plasma lipids, the reticuloendothelial system becomes overloaded with fat. In the setting of infection, this RES fat overload triggers the clinical-biological manifestations of FOS, including fever 1.

Type of Lipid Emulsion

The rate of infusion, not the type of lipid emulsion, is the primary determinant of FOS development 1. While FOS was historically described with soybean oil-based emulsions, it has been documented with newer composite emulsions including SMOFlipid (containing soy oil, medium-chain triglycerides, olive oil, and fish oil) 2. A case report of a 2-year-old with short bowel syndrome demonstrated identical FOS complications with SMOFlipid as previously seen with traditional Intralipid when accidentally infused very rapidly 2.

Prevention Strategy

To avoid fever and other FOS complications:

  • Control infusion rate carefully - this is the most critical factor
  • Monitor for signs of fat overload in high-risk situations (sepsis, infection, rapid infusion)
  • Be particularly vigilant in patients receiving high-dose or prolonged lipid therapy

Important Caveat

The fever associated with lipid infusion is not a benign, isolated finding but rather signals a potentially serious complication requiring immediate recognition and supportive management, including fluid resuscitation, platelet transfusion if needed, and albumin/fresh-frozen plasma replacement 2.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.